Cargando…

A prognostic model for ovarian cancer

About 6000 women in the United Kingdom develop ovarian cancer each year and about two-thirds of the women will die from the disease. Establishing the prognosis of a woman with ovarian cancer is an important part of her evaluation and treatment. Prognostic models and indices in ovarian cancer should...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, T G, Stewart, M E, Altman, D G, Gabra, H, Smyth, J F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375096/ https://www.ncbi.nlm.nih.gov/pubmed/11592763 http://dx.doi.org/10.1054/bjoc.2001.2030

Ejemplares similares

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines
por: Wilson, K E, et al.
Publicado: (1999)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer
por: McPhillips, F, et al.
Publicado: (2001)

DNA topoisomerase IIα and -β expression in human ovarian cancer
por: Withoff, S, et al.
Publicado: (1999)

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
por: Simpson, B J B, et al.
Publicado: (1999)

Ovarian cysts in women receiving tamoxifen for breast cancer
por: Mourits, M J E, et al.
Publicado: (1999)

CDKN2A gene inactivation in epithelial sporadic ovarian cancer
por: Niederacher, D, et al.
Publicado: (1999)

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
por: Peelen, T, et al.
Publicado: (2000)

Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Introduction to managing patients with recurrent ovarian cancer
por: Gabra, Hani
Publicado: (2014)

Ovarian cancer
por: Kerbrat, P, et al.
Publicado: (2001)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000)

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.
por: Gabra, H., et al.
Publicado: (1995)

Risk Model in Women with Ovarian Cancer Without Mutations
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Risk of ovarian cancer in relation to use of phenolphthalein-containing laxatives
por: Cooper, G S, et al.
Publicado: (2000)

Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma
por: Liu, C Q, et al.
Publicado: (1999)

Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer
por: Gore, M, et al.
Publicado: (2001)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
por: Balesaria, S, et al.
Publicado: (1999)

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
por: McFadyen, M C E, et al.
Publicado: (2001)

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
por: Windbichler, G H, et al.
Publicado: (2000)

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
por: Kolfschoten, G M, et al.
Publicado: (2000)

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
por: Houba, P H J, et al.
Publicado: (2001)

Risk of Ovarian Cancer Relapse Score: A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian Cancer
por: Rizzuto, Ivana, et al.
Publicado: (2015)

Modelling the effects of standard prognostic factors in node-positive breast cancer
por: Sauerbrei, W, et al.
Publicado: (1999)

The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer
por: Partridge, M, et al.
Publicado: (1999)

An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre
por: Sengupta, P S, et al.
Publicado: (1999)

Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)
por: Erba, E, et al.
Publicado: (2000)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Menstrual and reproductive factors in relation to ovarian cancer risk
por: Titus-Ernstoff, L, et al.
Publicado: (2001)

Collagen type XVIII/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas
por: Guenther, U, et al.
Publicado: (2001)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996)

Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
por: McDaid, H M, et al.
Publicado: (1999)

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
por: Ercoli, A, et al.
Publicado: (1999)

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
por: Vahteristo, P, et al.
Publicado: (2001)

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
por: Austrup, F, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_p9o12qgbcst8dair2soj8v1ch1